Comparison of Post-transplant Cyclophosphamide Containing Immunosuppressive Regimen with Standard Immunosuppressive Regimen in Allogeneic Stem Cell Transplantation from Matched Sibling Donor

Aim:Allogeneic stem cell transplantation (ASCT) is the only treatment that can cure most of malignant hematological diseases with the risk of some serious complications such as graft-versus-host disease (GVHD). GVHD can be got under control with post-transplant cyclophosphamide even in patients with...

Full description

Bibliographic Details
Main Authors: Osman KARA, Tayfun ELİBOL
Format: Article
Language:English
Published: Galenos Yayincilik 2021-12-01
Series:Namık Kemal Tıp Dergisi
Subjects:
Online Access: http://namikkemalmedj.com/archives/archive-detail/article-preview/comparison-of-post-transplant-cyclophosphamide-con/49752